img

Global CRISPR And CRISPR-Associated Genes Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CRISPR And CRISPR-Associated Genes Market Insights, Forecast to 2034

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Market Analysis and InsightsGlobal CRISPR And CRISPR-Associated Genes Market
Global CRISPR And CRISPR-Associated Genes market is expected to reach to US$ 1440.1 million in 2023, with a positive growth of %, compared with US$ 1384.4 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CRISPR And CRISPR-Associated Genes industry is evaluated to reach US$ 1770.3 million in 2033. The CAGR will be 3.5% during 2023 to 2033.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Report Covers
This report presents an overview of global CRISPR And CRISPR-Associated Genes market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global CRISPR And CRISPR-Associated Genes market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Segment by Application


Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, CRISPR And CRISPR-Associated Genes introduction, etc. CRISPR And CRISPR-Associated Genes Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of CRISPR And CRISPR-Associated Genes
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 GRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR And CRISPR-Associated Genes Market Perspective (2018-2033)
2.2 Global CRISPR And CRISPR-Associated Genes Growth Trends by Region
2.2.1 CRISPR And CRISPR-Associated Genes Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR And CRISPR-Associated Genes Historic Market Size by Region (2018-2023)
2.2.3 CRISPR And CRISPR-Associated Genes Forecasted Market Size by Region (2024-2033)
2.3 CRISPR And CRISPR-Associated Genes Market Dynamics
2.3.1 CRISPR And CRISPR-Associated Genes Industry Trends
2.3.2 CRISPR And CRISPR-Associated Genes Market Drivers
2.3.3 CRISPR And CRISPR-Associated Genes Market Challenges
2.3.4 CRISPR And CRISPR-Associated Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CRISPR And CRISPR-Associated Genes by Players
3.1.1 Global CRISPR And CRISPR-Associated Genes Revenue by Players (2018-2023)
3.1.2 Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR And CRISPR-Associated Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CRISPR And CRISPR-Associated Genes, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio
3.4.1 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR And CRISPR-Associated Genes Revenue in 2022
3.5 Global Key Players of CRISPR And CRISPR-Associated Genes Head office and Area Served
3.6 Global Key Players of CRISPR And CRISPR-Associated Genes, Product and Application
3.7 Global Key Players of CRISPR And CRISPR-Associated Genes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR And CRISPR-Associated Genes Breakdown Data by Type
4.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Type (2018-2023)
4.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2024-2033)
5 CRISPR And CRISPR-Associated Genes Breakdown Data by Application
5.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Application (2018-2023)
5.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
6.2 North America CRISPR And CRISPR-Associated Genes Market Size by Type
6.2.1 North America CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023)
6.2.2 North America CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033)
6.2.3 North America CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
6.3 North America CRISPR And CRISPR-Associated Genes Market Size by Application
6.3.1 North America CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023)
6.3.2 North America CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033)
6.3.3 North America CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
6.4 North America CRISPR And CRISPR-Associated Genes Market Size by Country
6.4.1 North America CRISPR And CRISPR-Associated Genes Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
6.4.3 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
7.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Type
7.2.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023)
7.2.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033)
7.2.3 Europe CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
7.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Application
7.3.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023)
7.3.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033)
7.3.3 Europe CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
7.4 Europe CRISPR And CRISPR-Associated Genes Market Size by Country
7.4.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
7.4.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
8.2 China CRISPR And CRISPR-Associated Genes Market Size by Type
8.2.1 China CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023)
8.2.2 China CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033)
8.2.3 China CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
8.3 China CRISPR And CRISPR-Associated Genes Market Size by Application
8.3.1 China CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023)
8.3.2 China CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033)
8.3.3 China CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
9.2 Asia CRISPR And CRISPR-Associated Genes Market Size by Type
9.2.1 Asia CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023)
9.2.2 Asia CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033)
9.2.3 Asia CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
9.3 Asia CRISPR And CRISPR-Associated Genes Market Size by Application
9.3.1 Asia CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023)
9.3.2 Asia CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033)
9.3.3 Asia CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
9.4 Asia CRISPR And CRISPR-Associated Genes Market Size by Region
9.4.1 Asia CRISPR And CRISPR-Associated Genes Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2023)
9.4.3 Asia CRISPR And CRISPR-Associated Genes Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Type
10.2.1 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Application
10.3.1 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Country
10.4.1 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.2.5 Editas Medicine Recent Developments
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Details
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.3.5 Caribou Biosciences Recent Developments
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Details
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.4.5 CRISPR therapeutics Recent Developments
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Details
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.5.5 Intellia therapeutics, Inc. Recent Developments
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR And CRISPR-Associated Genes Introduction
11.6.4 Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.6.5 Cellectis Recent Developments
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Details
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.7.5 Horizon Discovery Plc Recent Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Details
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.8.5 Sigma Aldrich Recent Developments
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Details
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.9.5 Precision Biosciences Recent Developments
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR And CRISPR-Associated Genes Introduction
11.10.4 Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.10.5 Genscript Recent Developments
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Details
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.11.5 Sangamo Biosciences Inc. Recent Developments
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Details
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.12.5 Lonza Group Limited Recent Developments
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Details
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.13.5 Integrated DNA Technologies Recent Developments
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.14.5 New England Biolabs Recent Developments
11.15 Origene Technologies
11.15.1 Origene Technologies Company Details
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.15.5 Origene Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of GRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 10. Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global CRISPR And CRISPR-Associated Genes Market Share by Region (2018-2023)
Table 13. Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global CRISPR And CRISPR-Associated Genes Market Share by Region (2024-2033)
Table 15. CRISPR And CRISPR-Associated Genes Market Trends
Table 16. CRISPR And CRISPR-Associated Genes Market Drivers
Table 17. CRISPR And CRISPR-Associated Genes Market Challenges
Table 18. CRISPR And CRISPR-Associated Genes Market Restraints
Table 19. Global CRISPR And CRISPR-Associated Genes Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global CRISPR And CRISPR-Associated Genes Revenue Share by Players (2018-2023)
Table 21. Global Top CRISPR And CRISPR-Associated Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR And CRISPR-Associated Genes as of 2022)
Table 22. Global CRISPR And CRISPR-Associated Genes Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by CRISPR And CRISPR-Associated Genes Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of CRISPR And CRISPR-Associated Genes, Headquarters and Area Served
Table 25. Global Key Players of CRISPR And CRISPR-Associated Genes, Product and Application
Table 26. Global Key Players of CRISPR And CRISPR-Associated Genes, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Type (2018-2023)
Table 30. Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Type (2024-2033)
Table 32. Global CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global CRISPR And CRISPR-Associated Genes Revenue Share by Application (2018-2023)
Table 34. Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global CRISPR And CRISPR-Associated Genes Revenue Share by Application (2024-2033)
Table 36. North America CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033) & (US$ Million)
Table 38. North America CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033) & (US$ Million)
Table 40. North America CRISPR And CRISPR-Associated Genes Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. North America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 43. Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033) & (US$ Million)
Table 45. Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033) & (US$ Million)
Table 47. Europe CRISPR And CRISPR-Associated Genes Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 50. China CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 51. China CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033) & (US$ Million)
Table 52. China CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 53. China CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033) & (US$ Million)
Table 56. Asia CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033) & (US$ Million)
Table 58. Asia CRISPR And CRISPR-Associated Genes Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 59. Asia CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia CRISPR And CRISPR-Associated Genes Market Size by Region (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2024-2033) & (US$ Million)
Table 65. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 66. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Product
Table 71. Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Editas Medicine Company Details
Table 74. Editas Medicine Business Overview
Table 75. Editas Medicine CRISPR And CRISPR-Associated Genes Product
Table 76. Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 77. Editas Medicine Recent Developments
Table 78. Caribou Biosciences Company Details
Table 79. Caribou Biosciences Business Overview
Table 80. Caribou Biosciences CRISPR And CRISPR-Associated Genes Product
Table 81. Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 82. Caribou Biosciences Recent Developments
Table 83. CRISPR therapeutics Company Details
Table 84. CRISPR therapeutics Business Overview
Table 85. CRISPR therapeutics CRISPR And CRISPR-Associated Genes Product
Table 86. CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 87. CRISPR therapeutics Recent Developments
Table 88. Intellia therapeutics, Inc. Company Details
Table 89. Intellia therapeutics, Inc. Business Overview
Table 90. Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Product
Table 91. Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 92. Intellia therapeutics, Inc. Recent Developments
Table 93. Cellectis Company Details
Table 94. Cellectis Business Overview
Table 95. Cellectis CRISPR And CRISPR-Associated Genes Product
Table 96. Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 97. Cellectis Recent Developments
Table 98. Horizon Discovery Plc Company Details
Table 99. Horizon Discovery Plc Business Overview
Table 100. Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Product
Table 101. Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 102. Horizon Discovery Plc Recent Developments
Table 103. Sigma Aldrich Company Details
Table 104. Sigma Aldrich Business Overview
Table 105. Sigma Aldrich CRISPR And CRISPR-Associated Genes Product
Table 106. Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 107. Sigma Aldrich Recent Developments
Table 108. Precision Biosciences Company Details
Table 109. Precision Biosciences Business Overview
Table 110. Precision Biosciences CRISPR And CRISPR-Associated Genes Product
Table 111. Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 112. Precision Biosciences Recent Developments
Table 113. Genscript Company Details
Table 114. Genscript Business Overview
Table 115. Genscript CRISPR And CRISPR-Associated Genes Product
Table 116. Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 117. Genscript Recent Developments
Table 118. Sangamo Biosciences Inc. Company Details
Table 119. Sangamo Biosciences Inc. Business Overview
Table 120. Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Product
Table 121. Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 122. Sangamo Biosciences Inc. Recent Developments
Table 123. Lonza Group Limited Company Details
Table 124. Lonza Group Limited Business Overview
Table 125. Lonza Group Limited CRISPR And CRISPR-Associated Genes Product
Table 126. Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 127. Lonza Group Limited Recent Developments
Table 128. Integrated DNA Technologies Company Details
Table 129. Integrated DNA Technologies Business Overview
Table 130. Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Product
Table 131. Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 132. Integrated DNA Technologies Recent Developments
Table 133. New England Biolabs Company Details
Table 134. New England Biolabs Business Overview
Table 135. New England Biolabs CRISPR And CRISPR-Associated Genes Product
Table 136. New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 137. New England Biolabs Recent Developments
Table 138. Origene Technologies Company Details
Table 139. Origene Technologies Business Overview
Table 140. Origene Technologies CRISPR And CRISPR-Associated Genes Product
Table 141. Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 142. Origene Technologies Recent Developments
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global CRISPR And CRISPR-Associated Genes Market Share by Type: 2022 VS 2033
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. GRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 11. Global CRISPR And CRISPR-Associated Genes Market Share by Application: 2022 VS 2033
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR And CRISPR-Associated Genes Report Years Considered
Figure 17. Global CRISPR And CRISPR-Associated Genes Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global CRISPR And CRISPR-Associated Genes Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global CRISPR And CRISPR-Associated Genes Market Share by Region: 2022 VS 2033
Figure 20. Global CRISPR And CRISPR-Associated Genes Market Share by Players in 2022
Figure 21. Global Top CRISPR And CRISPR-Associated Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR And CRISPR-Associated Genes as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR And CRISPR-Associated Genes Revenue in 2022
Figure 23. North America CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
Figure 25. North America CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
Figure 26. North America CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 27. United States CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Canada CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe CRISPR And CRISPR-Associated Genes Market Size YoY (2018-2033) & (US$ Million)
Figure 30. Europe CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
Figure 31. Europe CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
Figure 32. Europe CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 33. Germany CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. France CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. U.K. CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Italy CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Russia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Nordic Countries CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. China CRISPR And CRISPR-Associated Genes Market Size YoY (2018-2033) & (US$ Million)
Figure 40. China CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
Figure 41. China CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
Figure 42. Asia CRISPR And CRISPR-Associated Genes Market Size YoY (2018-2033) & (US$ Million)
Figure 43. Asia CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
Figure 44. Asia CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
Figure 45. Asia CRISPR And CRISPR-Associated Genes Market Share by Region (2018-2033)
Figure 46. Japan CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. South Korea CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. China Taiwan CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Southeast Asia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. India CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Australia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Size YoY (2018-2033) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Share by Type (2018-2033)
Figure 54. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Share by Application (2018-2033)
Figure 55. Middle East, Africa, and Latin America CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 56. Brazil CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Mexico CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Turkey CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Saudi Arabia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Israel CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. GCC Countries CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 63. Editas Medicine Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 64. Caribou Biosciences Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 65. CRISPR therapeutics Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 66. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 67. Cellectis Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 68. Horizon Discovery Plc Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 69. Sigma Aldrich Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 70. Precision Biosciences Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 71. Genscript Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 72. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 73. Lonza Group Limited Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 74. Integrated DNA Technologies Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 75. New England Biolabs Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 76. Origene Technologies Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries